MedTrace Logo

Study to Improve Outcomes in Aortic Stenosis

NCT03112629 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 791

Last updated 2020-02-26

No results posted yet for this study

Summary

Multi-centre, multi-national, observational, prospective registry in four central full access centres in Germany (2), France (1) and the United Kingdom (1) and up to two satellites per hub (smaller hospitals / office based cardiologists (OBC) without access to surgical and percutaneous aortic valve (AV) interventions).

The hypothesis is that the management of patients with severe AS will differ between sites with on-site access to all treatment modes and those without such facilities.

Conditions

  • Aortic Valve Stenosis

Sponsors & Collaborators

  • Edwards Lifesciences

    collaborator INDUSTRY

  • Institut für Pharmakologie und Präventive Medizin

    lead NETWORK

Principal Investigators

  • Stephan Balduss, Prof · University of Cologne

  • Norbert Frey, Prof · University of Kiel, Germany

  • Richard Steeds, Prof · Queen Elizabeth Hospital, Birmingham, UK

  • David Messika-Zeitoun, Prof · Bichat Hospital, Paris, France

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-23
Primary Completion
2019-03-12
Completion
2019-04-03

Countries

  • France
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03112629 on ClinicalTrials.gov